Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rosa

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
United European Gastroenterology Journal|December 9, 2024
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment OutcomesD Magalhaes, M Santiago, M Patita, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 18, 2019
The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in YouthMatti Cervin, Sean Perrin, Elin Olsson, et al.
Alimentary Pharmacology & Therapeutics|June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognitionJ Goncalves, M Santos, R Acurcio, et al.
Scientific Reports|October 7, 2025
COVID-19 and chronic liver disease: results from the 1219 patients French registryL Blaise, F Lebossé, C Costentin, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 2021
Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive DisorderLuis C Farhat, Edoardo F Q Vattimo, Divya Ramakrishnan, et al.
Physical Review Letters|September 27, 2024
Search for Leptonic Decays of Dark Photons at NA62E Cortina Gil, J Jerhot, A Kleimenova, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
United European Gastroenterology Journal|December 9, 2024
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment OutcomesD Magalhaes, M Santiago, M Patita, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 18, 2019
The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in YouthMatti Cervin, Sean Perrin, Elin Olsson, et al.
Alimentary Pharmacology & Therapeutics|June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognitionJ Goncalves, M Santos, R Acurcio, et al.
Scientific Reports|October 7, 2025
COVID-19 and chronic liver disease: results from the 1219 patients French registryL Blaise, F Lebossé, C Costentin, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 2021
Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive DisorderLuis C Farhat, Edoardo F Q Vattimo, Divya Ramakrishnan, et al.
Physical Review Letters|September 27, 2024
Search for Leptonic Decays of Dark Photons at NA62E Cortina Gil, J Jerhot, A Kleimenova, et al.
Pageof 9